30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Arcutis Biotherapeutics Inc (ARQT)

Track

Over the last 90 days, Arcutis Biotherapeutics Inc. has seen significant insider selling, with a net value of -$157,405.91 and a net of -4 executives selling shares. Notable transactions include proposed and planned sales by Director Howard Welgus and Officer Sue-Jean Lin in mid-June. This activity occurred following the last earnings report which missed expectations by 50%.
Stock chart
Ticker: ARQT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Welgus Howard G.
1 sale — total 100,000 USD
Planned sale 17 Jun 2026
Value US$540,635.76 | Price 414.71 | Shares 34,022
Proposed sale 17 Jun 2026
Value US$1,965,625.34 | Price 496.52 | Shares 20,610
Planned sale 15 Jun 2026
Value US$100,000.00 | Price 24.38 | Shares 1,000
Planned sale 15 Jun 2026
Value US$100,000.00 | Price 24.41 | Shares 1,000
Proposed sale 15 Jun 2026
Value US$100,000.00 | Price 24.38 | Shares 1,000
Proposed sale 15 Jun 2026
Value US$100,000.00 | Price 24.41 | Shares 1,000
Sale 11 May 2026
Value US$9,156.75 | Price 21.05 | Shares 435
Sale 11 May 2026
Value US$4,673.10 | Price 21.05 | Shares 222
Proposed sale 11 May 2026
Value US$4,673.10 | Price 21.05 | Shares 222
Proposed sale 11 May 2026
Value US$9,156.75 | Price 21.05 | Shares 435
Sale 4 May 2026
Value US$20,871.77 | Price 23.61 | Shares 884
Planned sale 4 May 2026
Value US$171,543.49 | Price 23.27 | Shares 7,372
Sale 4 May 2026
Value US$16,149.65 | Price 23.61 | Shares 684
Sale 4 May 2026
Value US$31,661.81 | Price 23.61 | Shares 1,341
Sale 4 May 2026
Value US$74,892.82 | Price 23.61 | Shares 3,172
Proposed sale 4 May 2026
Value US$31,661.81 | Price 23.61 | Shares 1,341
Proposed sale 4 May 2026
Value US$16,149.65 | Price 23.61 | Shares 684
Proposed sale 4 May 2026
Value US$74,892.82 | Price 23.61 | Shares 3,172
Proposed sale 4 May 2026
Value US$192,415.53 | Price 23.31 | Shares 8,256
Planned sale 1 May 2026
Value US$164,219.84 | Price 22.99 | Shares 7,144
Proposed sale 1 May 2026
Value US$164,219.71 | Price 22.99 | Shares 7,144
Planned sale 1 Apr 2026
Value US$238,801.00 | Price 23.88 | Shares 10,000
Proposed sale 1 Apr 2026
Value US$238,800.86 | Price 23.88 | Shares 10,000
Planned sale 2 Mar 2026
Value US$997,194.62 | Price 25.39 | Shares 39,272
Planned sale 2 Mar 2026
Value US$256,518.00 | Price 25.65 | Shares 10,000
Sale 2 Mar 2026
Value US$27,676.05 | Price 25.91 | Shares 1,068
Sale 2 Mar 2026
Value US$912,851.73 | Price 25.16 | Shares 36,281
Sale 2 Mar 2026
Value US$2,669.23 | Price 25.91 | Shares 103
Sale 2 Mar 2026
Value US$90,177.02 | Price 25.16 | Shares 3,584
Sale 2 Mar 2026
Value US$4,690.43 | Price 25.91 | Shares 181
Sale 2 Mar 2026
Value US$153,629.40 | Price 25.16 | Shares 6,106
Planned sale 2 Mar 2026
Value US$51,065.90 | Price 25.70 | Shares 1,987
Sale 2 Mar 2026
Value US$5,001.38 | Price 25.91 | Shares 193
Sale 2 Mar 2026
Value US$164,876.10 | Price 25.16 | Shares 6,553
Sale 2 Mar 2026
Value US$2,099.03 | Price 25.91 | Shares 81
Sale 2 Mar 2026
Value US$69,744.91 | Price 25.16 | Shares 2,772
Proposed sale 2 Mar 2026
Value US$313,878.00 | Price 26.03 | Shares 12,058
Proposed sale 2 Mar 2026
Value US$92,846.40 | Price 25.18 | Shares 3,687
Proposed sale 2 Mar 2026
Value US$71,844.53 | Price 25.18 | Shares 2,853
Proposed sale 2 Mar 2026
Value US$940,526.25 | Price 25.18 | Shares 37,349
Proposed sale 2 Mar 2026
Value US$158,319.86 | Price 25.18 | Shares 6,287
Proposed sale 2 Mar 2026
Value US$997,194.62 | Price 25.39 | Shares 39,272
Proposed sale 2 Mar 2026
Value US$256,517.50 | Price 25.65 | Shares 10,000
Planned sale 27 Feb 2026
Value US$92,933.75 | Price 27.95 | Shares 3,325
Planned sale 4 Feb 2026
Value US$252,747.88 | Price 25.81 | Shares 9,794
Planned sale 4 Feb 2026
Value US$252,747.88 | Price 25.81 | Shares 9,794
Proposed sale 4 Feb 2026
Value US$252,748.08 | Price 25.81 | Shares 9,794
Planned sale 2 Feb 2026
Value US$120,819.82 | Price 25.63 | Shares 4,714
Planned sale 2 Feb 2026
Value US$489,125.96 | Price 25.24 | Shares 19,379
Planned sale 2 Feb 2026
Value US$213,793.14 | Price 24.97 | Shares 8,562
Planned sale 2 Feb 2026
Value US$120,819.82 | Price 25.63 | Shares 4,714
Planned sale 2 Feb 2026
Value US$489,125.96 | Price 25.24 | Shares 19,379
Planned sale 2 Feb 2026
Value US$213,793.14 | Price 24.97 | Shares 8,562
Sale 2 Feb 2026
Value US$203,553.73 | Price 25.50 | Shares 7,983
Sale 2 Feb 2026
Value US$93,706.62 | Price 25.50 | Shares 3,675
Planned sale 2 Feb 2026
Value US$250,483.00 | Price 25.05 | Shares 10,000
Planned sale 2 Feb 2026
Value US$52,322.72 | Price 25.50 | Shares 2,052
Sale 2 Feb 2026
Value US$33,657.89 | Price 25.50 | Shares 1,320
Planned sale 2 Feb 2026
Value US$505,709.77 | Price 25.50 | Shares 19,833
Proposed sale 2 Feb 2026
Value US$1,027,275.00 | Price 25.28 | Shares 40,638
Proposed sale 2 Feb 2026
Value US$52,322.72 | Price 25.50 | Shares 2,052
Proposed sale 2 Feb 2026
Value US$33,657.89 | Price 25.50 | Shares 1,320
Proposed sale 2 Feb 2026
Value US$93,706.62 | Price 25.50 | Shares 3,675
Proposed sale 2 Feb 2026
Value US$505,710.00 | Price 25.50 | Shares 19,833
Proposed sale 2 Feb 2026
Value US$250,482.69 | Price 25.05 | Shares 10,000
Planned sale 5 Jan 2026
Value US$72,165.68 | Price 28.98 | Shares 2,490
Proposed sale 5 Jan 2026
Value US$72,165.70 | Price 28.98 | Shares 2,490
Planned sale 2 Jan 2026
Value US$289,606.00 | Price 28.96 | Shares 10,000
Proposed sale 2 Jan 2026
Value US$289,606.03 | Price 28.96 | Shares 10,000
Sale 31 Dec 2025
Value US$33,974.03 | Price 29.39 | Shares 1,156
Sale 31 Dec 2025
Value US$15,586.21 | Price 28.81 | Shares 541
Planned sale 15 Dec 2025
Value US$332,851.40 | Price 28.94 | Shares 11,500
Proposed sale 15 Dec 2025
Value US$332,851.03 | Price 28.94 | Shares 11,500
Planned sale 1 Dec 2025
Value US$302,133.00 | Price 30.21 | Shares 10,000
Planned sale 1 Dec 2025
Value US$50,091.11 | Price 30.23 | Shares 1,657
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-17 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
34,022 +30.3%
414.71
US$540,636 		34,022 +30.3% 414.71 US$540,636
2026-06-17 2026-06-17 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
20,610
496.52
US$1,965,625 		20,610 496.52 US$1,965,625
2026-06-17 2026-06-15 PlS Planned sale
3.1
LIN SUE-JEAN
Non-Executive Director
69,793 +47.5%
455.82
US$3,632,316 		69,793 +47.5% 455.82 US$3,632,316
2026-06-17 2026-06-15 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
1,000 -9.6%
24.41
US$100,000 		1,000 -9.6% 24.41 US$100,000
2026-06-15 2026-06-15 PrS Proposed sale
3.1
Sue-Jean Lin

Officer

Officer
1,000
24.38
US$100,000 		1,000 24.38 US$100,000
2026-06-15 2026-06-15 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
1,000
24.41
US$100,000 		1,000 24.41 US$100,000
2026-05-13 2026-05-11 S Sale
3.6
Vairavan Latha

SVP Chief Financial Officer

Officer
435 -0.5%
21.05
US$9,157 		435 -0.5% 21.05 US$9,157
2026-05-13 2026-05-11 S Sale
2.3
Burnett Patrick

See Remarks

Officer
222 -0.2%
21.05
US$4,673 		222 -0.2% 21.05 US$4,673
2026-05-11 2026-05-11 PrS Proposed sale
2.3
Patrick Burnett

Officer

Officer
222
21.05
US$4,673 		222 21.05 US$4,673
2026-05-11 2026-05-11 PrS Proposed sale
3.6
Latha Vairavan

officer

Officer
435
21.05
US$9,157 		435 21.05 US$9,157
2026-05-06 2026-05-04 S Sale
3.2
Matsuda Masaru

See Remarks

Officer
884 -0.7%
23.61
US$20,872 		884 -0.7% 23.61 US$20,872
2026-05-06 2026-05-04 PlS Planned sale
3.2
Matsuda Masaru

See Remarks

Officer
7,372 -5.5%
23.27
US$171,543 		7,372 -5.5% 23.27 US$171,543
2026-05-06 2026-05-04 S Sale
2.3
Burnett Patrick

See Remarks

Officer
684 -0.6%
23.61
US$16,150 		684 -0.6% 23.61 US$16,150
2026-05-06 2026-05-04 S Sale
3.6
Vairavan Latha

SVP Chief Financial Officer

Officer
1,341 -1.5%
23.61
US$31,662 		1,341 -1.5% 23.61 US$31,662
2026-05-06 2026-05-04 S Sale
2.5
Watanabe Todd

See Remarks

Executive Director
3,172 -0.4%
23.61
US$74,893 		3,172 -0.4% 23.61 US$74,893
2026-05-04 2026-05-04 PrS Proposed sale
3.6
Latha Vairavan

Officer

Officer
1,341
23.61
US$31,662 		1,341 23.61 US$31,662
2026-05-04 2026-05-04 PrS Proposed sale
2.3
Patrick Burnett

Officer

Officer
684
23.61
US$16,150 		684 23.61 US$16,150
2026-05-04 2026-05-04 PrS Proposed sale
2.5
Todd Watanabe

Officer

Officer
3,172
23.61
US$74,893 		3,172 23.61 US$74,893
2026-05-04 2026-05-04 PrS Proposed sale
3.2
Masaru Matsuda

officer

Officer
8,256
23.31
US$192,416 		8,256 23.31 US$192,416
2026-05-05 2026-05-01 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
7,144 -18.0%
22.99
US$164,220 		7,144 -18.0% 22.99 US$164,220
2026-05-01 2026-05-01 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
7,144
22.99
US$164,220 		7,144 22.99 US$164,220
2026-04-03 2026-04-01 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
10,000 -20.1%
23.88
US$238,801 		10,000 -20.1% 23.88 US$238,801
2026-04-01 2026-04-01 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
10,000
23.88
US$238,801 		10,000 23.88 US$238,801
2026-03-04 2026-03-02 PlS Planned sale
Leonard Keith R
Non-Executive Director
39,272 -64.0%
25.39
US$997,195 		39,272 -64.0% 25.39 US$997,195
2026-03-04 2026-03-02 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
10,000 -16.7%
25.65
US$256,518 		10,000 -16.7% 25.65 US$256,518
2026-03-03 2026-03-02 S Sale
2.5
Watanabe Todd

See Remarks

Executive Director
1,068 -0.1%
25.91
US$27,676 		1,068 -0.1% 25.91 US$27,676
2026-03-03 2026-03-02 S Sale
2.5
Watanabe Todd

See Remarks

Executive Director
36,281 -4.4%
25.16
US$912,852 		36,281 -4.4% 25.16 US$912,852
2026-03-03 2026-03-02 S Sale
2.5
Edwards Larry Todd

See Remarks

Officer
103 -0.1%
25.91
US$2,669 		103 -0.1% 25.91 US$2,669
2026-03-03 2026-03-02 S Sale
2.5
Edwards Larry Todd

See Remarks

Officer
3,584 -2.0%
25.16
US$90,177 		3,584 -2.0% 25.16 US$90,177
2026-03-03 2026-03-02 S Sale
2.3
Burnett Patrick

See Remarks

Officer
181 -0.1%
25.91
US$4,690 		181 -0.1% 25.91 US$4,690
2026-03-03 2026-03-02 S Sale
2.3
Burnett Patrick

See Remarks

Officer
6,106 -4.8%
25.16
US$153,629 		6,106 -4.8% 25.16 US$153,629
2026-03-03 2026-03-02 PlS Planned sale
3.2
Matsuda Masaru

See Remarks

Officer
1,987 -1.4%
25.70
US$51,066 		1,987 -1.4% 25.70 US$51,066
2026-03-03 2026-03-02 S Sale
3.2
Matsuda Masaru

See Remarks

Officer
193 -0.1%
25.91
US$5,001 		193 -0.1% 25.91 US$5,001
2026-03-03 2026-03-02 S Sale
3.2
Matsuda Masaru

See Remarks

Officer
6,553 -4.6%
25.16
US$164,876 		6,553 -4.6% 25.16 US$164,876
2026-03-03 2026-03-02 S Sale
3.6
Vairavan Latha

SVP Chief Financial Officer

Officer
81 -0.1%
25.91
US$2,099 		81 -0.1% 25.91 US$2,099
2026-03-03 2026-03-02 S Sale
3.6
Vairavan Latha

SVP Chief Financial Officer

Officer
2,772 -3.1%
25.16
US$69,745 		2,772 -3.1% 25.16 US$69,745
2026-03-02 2026-03-02 PrS Proposed sale
3.2
Masaru Matsuda

officer

Officer
12,058
26.03
US$313,878 		12,058 26.03 US$313,878
2026-03-02 2026-03-02 PrS Proposed sale
2.5
Larry Todd Edwards

Officer

Officer
3,687
25.18
US$92,846 		3,687 25.18 US$92,846
2026-03-02 2026-03-02 PrS Proposed sale
3.6
Latha Vairavan

officer

Officer
2,853
25.18
US$71,845 		2,853 25.18 US$71,845
2026-03-02 2026-03-02 PrS Proposed sale
2.5
Todd Watanabe

Officer

Officer
37,349
25.18
US$940,526 		37,349 25.18 US$940,526
2026-03-02 2026-03-02 PrS Proposed sale
2.3
Patrick Burnett

Officer

Officer
6,287
25.18
US$158,320 		6,287 25.18 US$158,320
2026-03-02 2026-03-02 PrS Proposed sale
Keith Leonard

Board of Director

Non-Executive Director
39,272
25.39
US$997,195 		39,272 25.39 US$997,195
2026-03-02 2026-03-02 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
10,000
25.65
US$256,518 		10,000 25.65 US$256,518
2026-03-03 2026-02-27 PlS Planned sale
3.2
Matsuda Masaru

See Remarks

Officer
3,325 -2.3%
27.95
US$92,934 		3,325 -2.3% 27.95 US$92,934
2026-02-04 2026-02-04 PlS Planned sale
2.3
Burnett Patrick

See Remarks

Officer
9,794 -10.8%
25.81
US$252,748 		9,794 -10.8% 25.81 US$252,748
2026-02-04 2026-02-04 PlS Planned sale
2.3
Burnett Patrick

See Remarks

Officer
9,794 -10.8%
25.81
US$252,748 		9,794 -10.8% 25.81 US$252,748
2026-02-04 2026-02-04 PrS Proposed sale
2.3
Patrick Burnett

Officer

Officer
9,794
25.81
US$252,748 		9,794 25.81 US$252,748
2026-02-04 2026-02-02 PlS Planned sale
3.2
Matsuda Masaru

See Remarks

Officer
4,714 -4.1%
25.63
US$120,820 		4,714 -4.1% 25.63 US$120,820
2026-02-04 2026-02-02 PlS Planned sale
3.2
Matsuda Masaru

See Remarks

Officer
19,379 -14.5%
25.24
US$489,126 		19,379 -14.5% 25.24 US$489,126
2026-02-04 2026-02-02 PlS Planned sale
3.2
Matsuda Masaru

See Remarks

Officer
8,562 -6.0%
24.97
US$213,793 		8,562 -6.0% 24.97 US$213,793
2026-02-04 2026-02-02 PlS Planned sale
3.2
Matsuda Masaru

See Remarks

Officer
4,714 -4.1%
25.63
US$120,820 		4,714 -4.1% 25.63 US$120,820
2026-02-04 2026-02-02 PlS Planned sale
3.2
Matsuda Masaru

See Remarks

Officer
19,379 -14.5%
25.24
US$489,126 		19,379 -14.5% 25.24 US$489,126
2026-02-04 2026-02-02 PlS Planned sale
3.2
Matsuda Masaru

See Remarks

Officer
8,562 -6.0%
24.97
US$213,793 		8,562 -6.0% 24.97 US$213,793
2026-02-04 2026-02-02 S Sale
3.2
Matsuda Masaru

See Remarks

Officer
7,983 -5.3%
25.50
US$203,554 		7,983 -5.3% 25.50 US$203,554
2026-02-04 2026-02-02 S Sale
2.3
Burnett Patrick

See Remarks

Officer
3,675 -3.9%
25.50
US$93,707 		3,675 -3.9% 25.50 US$93,707
2026-02-04 2026-02-02 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
10,000 -14.3%
25.05
US$250,483 		10,000 -14.3% 25.05 US$250,483
2026-02-04 2026-02-02 PlS Planned sale
2.5
Edwards Larry Todd

See Remarks

Officer
2,052 -1.4%
25.50
US$52,323 		2,052 -1.4% 25.50 US$52,323
2026-02-04 2026-02-02 S Sale
3.6
Vairavan Latha

SVP Chief Financial Officer

Officer
1,320 -2.0%
25.50
US$33,658 		1,320 -2.0% 25.50 US$33,658
2026-02-04 2026-02-02 PlS Planned sale
2.5
Watanabe Todd

See Remarks

Executive Director
19,833 -2.7%
25.50
US$505,710 		19,833 -2.7% 25.50 US$505,710
2026-02-02 2026-02-02 PrS Proposed sale
3.2
Masaru Matsuda

officer

Officer
40,638
25.28
US$1,027,275 		40,638 25.28 US$1,027,275
2026-02-02 2026-02-02 PrS Proposed sale
2.5
Todd Edwards

Officer

Officer
2,052
25.50
US$52,323 		2,052 25.50 US$52,323
2026-02-02 2026-02-02 PrS Proposed sale
3.6
Latha Vairavan

Officer

Officer
1,320
25.50
US$33,658 		1,320 25.50 US$33,658
2026-02-02 2026-02-02 PrS Proposed sale
2.3
Patrick Burnett

Officer

Officer
3,675
25.50
US$93,707 		3,675 25.50 US$93,707
2026-02-02 2026-02-02 PrS Proposed sale
2.5
Todd Frank Watanabe

officer

Officer
19,833
25.50
US$505,710 		19,833 25.50 US$505,710
2026-02-02 2026-02-02 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
10,000
25.05
US$250,483 		10,000 25.05 US$250,483
2026-01-07 2026-01-05 PlS Planned sale
2.3
Burnett Patrick

See Remarks

Officer
2,490 -2.6%
28.98
US$72,166 		2,490 -2.6% 28.98 US$72,166
2026-01-05 2026-01-05 PrS Proposed sale
2.3
Patrick Burnett

Officer

Officer
2,490
28.98
US$72,166 		2,490 28.98 US$72,166
2026-01-06 2026-01-02 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
10,000 -12.5%
28.96
US$289,606 		10,000 -12.5% 28.96 US$289,606
2026-01-02 2026-01-02 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
10,000
28.96
US$289,606 		10,000 28.96 US$289,606
2026-01-02 2025-12-31 S Sale
2.3
Burnett Patrick

See Remarks

Officer
1,156 -1.2%
29.39
US$33,974 		1,156 -1.2% 29.39 US$33,974
2026-01-02 2025-12-31 S Sale
2.3
Burnett Patrick

See Remarks

Officer
541 -0.6%
28.81
US$15,586 		541 -0.6% 28.81 US$15,586
2025-12-17 2025-12-15 PlS Planned sale
2.3
Burnett Patrick

See Remarks

Officer
11,500 -10.5%
28.94
US$332,851 		11,500 -10.5% 28.94 US$332,851
2025-12-15 2025-12-15 PrS Proposed sale
2.3
Patrick Burnett

Officer

Officer
11,500
28.94
US$332,851 		11,500 28.94 US$332,851
2025-12-03 2025-12-01 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
10,000 -11.1%
30.21
US$302,133 		10,000 -11.1% 30.21 US$302,133
2025-12-03 2025-12-01 PlS Planned sale
3.2
Matsuda Masaru

See Remarks

Officer
1,657 -1.1%
30.23
US$50,091 		1,657 -1.1% 30.23 US$50,091
Explore more

More insider trading research around Arcutis Biotherapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America